Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37573| Title: | How to perform first trimester combined screening for pre-eclampsia. | Authors: | Rolnik D.L. ;Reddy M. ;da Silva Costa F.;Springhall E.A. | Institution: | (Reddy, Springhall, Rolnik, da Silva Costa) Perinatal Services, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, Australia (Reddy, da Silva Costa) Department of Obstetrics and Gynaecology, Monash University, 246 Clayton Road, Clayton, VIC, Australia (da Silva Costa) Monash Ultrasound for Women, Melbourne, VIC, Australia | Issue Date: | 27-Nov-2018 | Copyright year: | 2018 | Publisher: | John Wiley and Sons Inc. (E-mail: cs-journals@wiley.com) | Place of publication: | United States | Publication information: | Australasian Journal of Ultrasound in Medicine. 21 (4) (pp 191-197), 2018. Date of Publication: November 2018. | Abstract: | Pre-eclampsia is a common condition that affects 2-5% of pregnancies and is associated with significant maternal and perinatal morbidity, and cost to the healthcare system. In those at high risk for pre-eclampsia, interventions such as aspirin intake have been shown to reduce prevalence of disease. However, to implement these interventions, it is essential that high-risk women be identified early in pregnancy. A combined first trimester screening model for pre-eclampsia that includes maternal history, mean arterial pressure, uterine artery Doppler and PlGF has been shown to be the most effective at identifying the population at greatest risk of pre-eclampsia. This article will explore the most appropriate methods of measuring the components of first trimester screening and discuss the use of aspirin for prevention of pre-eclampsia in pregnancy.Copyright © 2018 Australasian Society for Ultrasound in Medicine | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/ajum.12111 | ORCID: | Reddy, Maya; ORCID: http://orcid.org/0000-0002-4251-7193 Rolnik, Daniel Lorber; ORCID: http://orcid.org/0000-0002-2263-3592 | Link to associated publication: | Click here for full text options | ISSN: | 1836-6864 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/37573 | Type: | Article | Subjects: | DELFIA echography enzyme linked immunosorbent assay female fetus growth *first trimester pregnancy gestational age health care cost human intrauterine growth retardation maternal age mean arterial pressure pathophysiology perinatal morbidity practice guideline *preeclampsia/di [Diagnosis] *preeclampsia/dt [Drug Therapy] premature labor pulsatility index risk factor screening systolic blood pressure transvaginal echography trophoblast uterine artery acetylsalicylic acid/dt [Drug Therapy] biochemical marker/ec [Endogenous Compound] placental growth factor/ec [Endogenous Compound] pregnancy associated plasma protein A/ec [Endogenous Compound] autoanalyzer diastolic blood pressure Doppler flowmetry article body mass cell invasion intrauterine growth retardation maternal age mean arterial pressure pathophysiology perinatal morbidity practice guideline *preeclampsia / *diagnosis / *drug therapy premature labor pulsatility index risk factor screening systolic blood pressure transvaginal echography trophoblast uterine artery gestational age *first trimester pregnancy fetus growth female enzyme linked immunosorbent assay echography Doppler flowmetry diastolic blood pressure Article human cell invasion body mass health care cost |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.